XING Xiyue, ZHANG Wen, ZHANG Hong. Effect of Tongxinluo Capsule and Ganlu Xiaoke Capsule combined with routine treatment of western medicine for coronary heart disease complicated with diabetes[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 68-71. DOI: 10.7619/jcmp.201912020
Citation: XING Xiyue, ZHANG Wen, ZHANG Hong. Effect of Tongxinluo Capsule and Ganlu Xiaoke Capsule combined with routine treatment of western medicine for coronary heart disease complicated with diabetes[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 68-71. DOI: 10.7619/jcmp.201912020

Effect of Tongxinluo Capsule and Ganlu Xiaoke Capsule combined with routine treatment of western medicine for coronary heart disease complicated with diabetes

More Information
  • Received Date: May 03, 2019
  • Accepted Date: June 19, 2019
  • Available Online: February 22, 2021
  • Published Date: June 27, 2019
  •   Objective  To study the efficacy of Tongxinluo Capsule and Ganlu Xiaoke Capsule combined with routine treatment of western medicine in the treatment of coronary heart disease with diabetes mellitus.
      Methods  A total of 200 patients with coronary heart disease and diabetes mellitus treated in our hospital were selected as study subjects. According to the random number table method, the patients were randomly divided into control group and intervention group, with 100 cases in each group. Patients in the control group were treated with western medicine such as anti-coronary heart disease drugs and routine hypoglycemia treatment, while those in the intervention group were treated with Tongxinluo Capsule and Ganlu Xiaoke Capsule on the basis of the control group. The duration of angina, the times of attack, the dosage of nitroglycerin, hemorheological parameters, the efficacy of electrocardiogram and blood sugar control were compared and analyzed between the two groups.
      Results  Before treatment, there were no significant differences in duration of angina, attack times and nitroglycerin dosage between the two groups (P>0.05). After treatment, the above indicators in the intervention group were significantly lower than that in the control group (P < 0.05). After treatment, the whole blood viscosity, hematocrit and blood viscosity of the intervention group were significantly lower than those of the control group (P < 0.05), and the effective rate of ECG in the intervention group was significantly higher than that of the control group (88.00% vs. 63.00%, P < 0.05). The total effective rate of blood sugar control in intervention group was significantly higher than that in intervention group (96.00% vs. 79.00%, P < 0.05).
      Conclusion  Tongxinluo Capsule and Ganlu Xiaoke Capsule combined with western medicine can significantly improve cardiovascular damage caused by abnormal glucose and lipid metabolism, and significantly reduce hemodynamic parameters, improve microcirculation, and reduce angina duration, attack times and the amount of medication forpatients with coronary heart disease and diabetes.
  • [1]
    周群芳. 中西医结合整体护理模式对住院2型糖尿病的临床干预效果评价[J]. 内蒙古中医药, 2017, 36(15): 174-174. doi: 10.3969/j.issn.1006-0979.2017.15.151
    [2]
    丁庆龙, 王琴. 糖尿病肾病中西医发病机制的研究进展[J]. 中国中医药现代远程教育, 2019, 17(4): 154-156. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYY201904069.htm
    [3]
    王咏梅. 多样性护理方式在糖尿病合并冠心病患者护理中的应用效果观察[J]. 实用临床医药杂志, 2015, 19(4): 13-16. doi: 10.7619/jcmp.201504005
    [4]
    刘建飞, 黄鹤. 血清MIF、MMP-9、TNF-α水平诊断冠心病合并糖尿病的临床价值[J]. 实用临床医药杂志, 2016, 20(17): 11-14. doi: 10.7619/jcmp.201617004
    [5]
    徐济民. 缺血性心脏病诊断的命名及标准-国际心脏病学会和协会/世界卫生组织临床命名标准化专题组的联合报告[J]. 国际心血管病杂志, 1979, 7(6): 365-366. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXX197906003.htm
    [6]
    毕颖斐, 毛静远, 郑颖, 等. 中医及中西医结合心脏康复发展现状[J]. 中西医结合心脑血管病杂志, 2016, 14(14): 1616-1618. doi: 10.3969/j.issn.1672-1349.2016.14.016
    [7]
    桂伟, 胡霞, 唐宏图, 等. 中西医结合治疗糖尿病周围神经病变的临床研究[J]. 辽宁中医杂志, 2016, 43(1): 101-103. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201601045.htm
    [8]
    吴朦, 胡镜清, 江丽杰, 等. 冠心病中医证分类及其关联理化指标的研究[J]. 世界科学技术: 中医药现代化, 2016, 18(5): 776-785. doi: 10.11842/wst.2016.05.011
    [9]
    段飞, 祝珍珍, 胡镜清, 等. 冠心病中医"证"的诊断及其规范化研究进展[J]. 中医学报, 2016, 31(11): 1771-1776. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201611040.htm
    [10]
    吴舒窈, 刘艳, 宋倩. 冠心病发病及预后的影响因素研究[J]. 中国全科医学, 2018, 21(29): 3562-3570. doi: 10.3969/j.issn.1007-9572.2018.00.249
    [11]
    杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学: 生命科学, 2018, 48(8): 812-819. https://www.cnki.com.cn/Article/CJFDTOTAL-JCXK201808003.htm
    [12]
    赵进喜, 王世东, 黄为钧, 等. 中医药防治糖尿病及其并发症研究述评[J]. 世界中医药, 2017, 12(1): 10-15. doi: 10.3969/j.issn.1673-7202.2017.01.003
    [13]
    韩玉亭, 孙正凯, 宫振霞, 等. 个体化健康管理模式对糖尿病合并冠心病患者自我效能感及遵医行为的影响[J]. 山东医药, 2016, 56(38): 65-67. doi: 10.3969/j.issn.1002-266X.2016.38.023
    [14]
    宋明, 陈家旭. 基于五诊十纲探讨中西医结合诊断的临床思维模式[J]. 北京中医药大学学报, 2018, 41(4): 269-273. doi: 10.3969/j.issn.1006-2157.2018.04.001
    [15]
    孙一鑫, 周一帆, 程吟楚, 等. 阿卡波糖与2型糖尿病患者冠心病发病风险的回顾性队列研究[J]. 药物流行病学杂志, 2018, 27(10): 663-668. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLX201810006.htm
    [16]
    王泽, 黄达, 孙丰卉, 等. 糖尿病合并冠心病中医证型研究进展[J]. 河北中医, 2018, 40(12): 1903-1908. doi: 10.3969/j.issn.1002-2619.2018.12.032
    [17]
    朱真灵, 金智生, 魏玉娇. 中西医结合治疗糖尿病周围神经病变研究进展[J]. 甘肃中医学院学报, 2014, 31(2): 87-90. https://www.cnki.com.cn/Article/CJFDTOTAL-GSZX201402037.htm
    [18]
    李金根, 徐浩, 史大卓. 冠心病中西医结合随机对照临床研究: 进展与展望[J]. 中国中西医结合杂志, 2017, 37(5): 517-521. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201705001.htm
  • Cited by

    Periodical cited type(5)

    1. 汤思,陈学杰. 直接抗人球蛋白试验阳性分型与输血疗效的相关性. 吉林医学. 2024(02): 295-297 .
    2. 杨占甲,李丽娟,宋银森. 多发性骨髓瘤患者红细胞输注效果的影响因素探讨. 中国实用医刊. 2024(13): 66-69 .
    3. 梁冬香,钟昌瑞,傅春花,邱启东. 直接抗人球蛋白试验凝集强度的结果分析及临床意义. 临床血液学杂志. 2024(12): 905-908 .
    4. 闻才李,张慧,杨吉岳,孙一心,程晓文. 直接抗人球蛋白试验阳性患者298例的病因回顾性分析. 医药论坛杂志. 2022(08): 72-74+78 .
    5. 胡泽斌,孙彬裕,孙晶,王布强,于婷. 抗人球蛋白检测卡行业标准的研究. 中国医药生物技术. 2022(05): 449-452 .

    Other cited types(0)

Catalog

    Article views (171) PDF downloads (5) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return